ArticleMetabolism open2026
Causal relationship between plasma metabolites and chronic regional pain: a Mendelian randomization study.
Article in Metabolism open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic pain imposes an enormous economic and personal health burden worldwide, with more than one-third of the population affected. However, no studies have systematically analyzed the potential role of plasma metabolites in chronic pain. This study aimed to perform an exploratory, hypothesis-generating Mendelian randomization (MR) analysis to identify candidate metabolite-pain relationships. Methods: Pooled genome-wide association study (GWAS) data for 1400 plasma metabolites from previous research was used as exposures and genetic data from the UK Biobank related to eight chronic regional pains were used as outcomes, including headache, facial pain, neck and shoulder pain, back pain, hip pain, stomachache, knee pain, and general pain. Instrumental variables (IVs) for metabolites were selected at a significance threshold of Results: MR analyses identified 122 plasma metabolites associated with eight chronic pain conditions, yielding a total of 126 associations with evidence suggestive of causality, with six metabolites implicated in more than one pain condition. Among these conditions, 63 were identified as protective factors for chronic regional pain and 63 as risk factors. Sensitivity analyses and heterogeneity tests supported the robustness of these findings. Reverse MR analysis indicated that neck and shoulder pain was associated with a decreased AMP-to-N-palmitoyl-sphingosine ratio. Conclusions: This exploratory, hypothesis-generating MR study identifies candidate plasma metabolites and metabolic pathways potentially involved in chronic pain susceptibility across multiple anatomical sites. These findings provide a foundation for future experimental and clinical studies to further investigate metabolite-related mechanisms and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.